Who's going to take the left mains?

Folia Cardiologica

Volumn 14, Issue 1, 2007, Pages 6-10

  Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; CARDIOGENIC SHOCK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIRECTIONAL ATHERECTOMY; DRUG EFFICACY; DRUG ELUTING STENT; EDITORIAL; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MEDICAL ETHICS; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; ST SEGMENT ELEVATION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 34247489401     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. ACC/AHA Guideline update for Coronary Artery Bypass graft Surgery. Circulation, 2004; 110: 1168-1176.
2. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelenes for Percutaneous Coronary Interventions. Silber S, Albertson P, Aviles FF et al. (members) Eur Heart J, 2005; 26: 804-847.
3. O'Keefe JH, Hartzler GO, Rutherford BD et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol, 1989; 64: 144-147.
4. Eldar M, Schulhoff RN, Hertz I et al. Results of percutaneous transluminal angioplasty of the left main coronary artery. Am J Cardiol, 1991; 68: 255-256.
5. Takagi T, Stankovic G, Finci S et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation, 2002; 106: 698-702.
6. Baim DS. Is it time to offer elective percutaneous treatment of the unprotected left main coronary artery? J Am Coll Cardiol, 2000; 35: 1551-1553.
7. Sanz AJ, Hernandez F, Tascon JC. Thrombotic occlusion of the left main coronary artery during coronary angiography. J Invasiv Cardiol, 2002; 14: 426-429.
8. Ammann P, Straumann E, Naegeli B et al. Long - term results after acute percutaneous transluminal coronary angioplasty in acute myocardial infarction and cardiogenic shock. Int J Cardiol, 2002; 82: 127-131.
9. Ramondo A, Favero L, Chioin R. Emergency stenting of the unprotected left main coronary artery. Ital Heart J, 2002; 3: 72-74.
10. Neri R, Migliorini A, Moschi K et al. Percutaneous reperfusion of left main coronary disease complicated by acute myocardial infarction. Catheter Cardiovasc Interv, 2002; 56: 31.
11. Wiśniewska-Szmyt J, Kubica J, Sukiennik A. One - year outcomes of left main coronary artery stenting in patients with cardiogenic shock. Cardiology Journal, 2007; 14: 67-75.
12. Park SJ, Park SW, Hong MK et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol, 1998; 31: 37-42.
13. Park SJ, Park SW, Hong MK et al. Long-term (three - year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol, 2003; 91:12-16.
14. Park SJ, Lee CW, Kim YH et al. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing. Am J Cardiol, 2002; 90: 374-378.
15. Laster SB, Rutherford BD, Mc Conahay DR et al. Directional atherectomy of left main stenoses. Cathet Cardiovasc Diagnosis, 1994; 33: 317-322.
16. Ellis SG, Tamai H, Nobuyoshi M. Contemporary Percutaneous Treatment of Unprotected Left Main Coronary Stenoses. Initial Results From a Multicenter Registry Analysis 1994-1996. Circulation, 1997; 96: 3867-3872.
17. De Lezo JS, Medina A, Romero Metal. Predictors of restenosis followig unprotected left main coronary stnting. Am J Cardiol, 2001; 88: 308-310.
18. Park SJ, Hong MK, Lee CW et al. Elective stenting of unprotected left main coronary artery stenosis. Efect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol, 2001; 38: 1054-1060.
19. Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J, 2006; 152: 896-902.
20. Kim YH, Park SW, Hong MK et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol, 2006; 97: 1597-1601.
21. Carrie D, Lhermusier T, Hmen M et al. Clinical and angiographic outcome of paklitaxel-eluting stent implantation for unprotected left main coronary artery bifurcation narrowing. Eurointerv, 2006; 1: 396-402.
22. Chieffo A, Stankovic G, Bonizzoni E et al. Elary and mid-term results of drug eluting stent implantation in unprotected left main. Circulation, 2005; 111: 791-795.
23. De Lezo JS, Medina A, Pan M. et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J, 2004; 148: 481-485.
24. Lee SH, Ko YG, Jang Y et al. Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis. Cardiology, 2005; 104: 181-185.
25. Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol, 2006; 47: 1530-1537.
26. Dudek D, Heba G, Giszterowicz D et al. Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting. Kardiol Pol, 2006; 64: 929-935.
27. Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 2006; 47: 871-877.
28. Kappetein AP, Dawkins KD, Mohr FW et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg, 2006; 29: 486-491.
29. Ong AT, Serruys PW, Mohr FW et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J, 2006; 151: 1194-1204.
30. Buszman P, Dudek D, Kiesz S et al. Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison with Surgical Revascularisation: LE MANS Case Controlled Study. Kardiol Pol, 2005; 63 (3 suppl 1): S185 (abstract).